Tag: Prescription Drugs
Treatment Response to Antiseizure Medications Can Take More Than One Year
Most participants with newly diagnosed focal episodes achieve seizure freedom; 27 percent become seizure-free with first ASM
Benefits of Long-Term Routine Lab Drug Toxicity Monitoring Unclear in RA
New very abnormal results mostly occur after DMARD dose increase, often already known or suspected
Discontinuation of Medical Cannabis Common in Musculoskeletal Pain
Many patients discontinue medical cannabis within one year, with higher rates for older patients
Apitegromab Improves Motor Function in Spinal Muscular Atrophy
Significant improvement seen in motor function for patients in combined 20- and 10-mg/kg dose groups versus placebo group
FDA Approves Papzimeos for Adults With Recurrent Respiratory Papillomatosis
Papzimeos is the first and only FDA-approved therapy for the treatment of adults with recurrent respiratory papillomatosis
Weather Disasters Impacted Counties With More Than 60 Percent of Drug Production Facilities
All types of climate-related disasters were declared in at least one county with an active drug production facility, with hurricanes most common
Use of Vaginal Estradiol Tablets Not Linked to Recurrent Stroke
Exposure to vaginal estradiol not linked to increased rate of recurrent ischemic stroke when adjusted for comorbidity, medications, income, education
FDA Approves Papzimeos for Adults With Recurrent Respiratory Papillomatosis
Papzimeos is the first and only FDA-approved therapy for the treatment of adults with recurrent respiratory papillomatosis
Molgramostim Beneficial in Autoimmune Pulmonary Alveolar Proteinosis
Once-daily inhaled molgramostim leads to greater increase in pulmonary gas transfer than placebo
Stapokibart Found to Be Superior to Placebo for Severe Chronic Rhinosinusitis With Polyps
Benefits include reduced polyp size and severity of nasal symptoms at 24 weeks
